Outlook Therapeutics, Inc. (OTLK): Form 8-K filed 2026-07-16

Items reported

Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
The company amended its articles of incorporation or bylaws without a shareholder vote that was previously disclosed, or changed its fiscal year.
Item 5.07: Submission of Matters to a Vote of Security Holders
The company reports the results of a shareholder meeting: each matter voted on and the votes cast for, against, abstaining and broker non-votes.
Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Type	Description	Document
8-K	FORM 8-K	tm2620677d1_8k.htm
EX-3.1	EXHIBIT 3.1	tm2620677d1_3-1.htm

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.